16 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
under the Securities Act.
The audit committee’s main purpose is to oversee our corporate accounting and financial reporting process. Our audit
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
is to oversee our corporate accounting and financial reporting process. Our audit committee will be responsible for, among other things:
selecting
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
Act.
The audit committee’s main purpose is to oversee our corporate accounting and financial reporting process. Our audit committee
S-1
EX-99.1
655uz v079fv
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.4
aqn3t6
29 Jun 23
IPO registration
4:39pm
S-1
ydnz6b3b
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.2
sg0oxv q8hedwxf
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-99.2
amew9
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
ists0ezalrh 3z
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-99.1
hgrs3ja
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
yrtxd3
2 May 23
Draft registration statement (amended)
12:00am
DRS
66s8 9239
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next